| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
21,161 |
16,138 |
$1.61M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,272 |
6,165 |
$504K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,573 |
3,904 |
$381K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,286 |
4,484 |
$285K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,184 |
3,293 |
$241K |
| 99051 |
|
10,499 |
7,810 |
$93K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
580 |
213 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
51 |
30 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
194 |
130 |
$1K |
| 99072 |
|
767 |
461 |
$0.00 |
| 81003 |
|
48 |
31 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
218 |
164 |
$0.00 |
| 99000 |
|
128 |
91 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
57 |
40 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
52 |
39 |
$0.00 |